Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-Like Episodes (MELAS), in Two Mexican Families

Case Report

Austin J Clin Case Rep. 2025; 12(1): 1351.

Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-Like Episodes (MELAS), in Two Mexican Families

Balderas Correa JJ1, Romo Calvillo HB1, Sánchez Mendoza AE2, Luna Muñoz J3 and Montiel Sosa JF2*

¹Unidad de Investigación Multidisciplinaria Laboratorio 18, FESC, Universidad Nacional Autónoma de México, (UNAM), México

²Departamento de Ciencias Biológicas, FESC, UNAM, México

³Universidad de Pachuca, México

*Corresponding author: Montiel Sosa JF, Unidad de Investigación Multidisciplinaria Laboratorio 18, Universidad Nacional Autónoma de México, México. Carretera Cuautitlán Teoloyucan Km 2.5, San Sebastian Xhala, 54714, Cuautitlán Izcalli, Estado de México, México Tel: +525523995678; Email: fmontiel_sosa@yahoo.com.mx

Received: February 21, 2025; Accepted: March 12, 2025; Published: March 17, 2025;

Abstract

MELAS syndrome is a mitochondrial disorder primarily affecting the nervous and muscular systems, often associated with the m.3243A>G mutation in the MT-TL1 gene. The severity of symptoms depends on heteroplasmy levels, which vary between individuals and tissues. Two Mexican families with suspected MELAS were studied. Peripheral blood samples were analyzed using PCRRFLP. The m.3243A>G mutation was detected in all individuals. In Family 1, the symptomatic son had 17% heteroplasmy, while the asymptomatic mother and brother had 23% and 13%, respectively. In Family 2, the mother and daughter showed 7.7% and 22.8% heteroplasmy, both asymptomatic. Genetic testing is crucial for MELAS diagnosis, even in asymptomatic carriers. The variability in heteroplasmy levels underscores the need for complementary analyses, such as muscle biopsy sequencing, for a more precise diagnosis.

Keywords: MELAS; Mitochondrial DNA; m.3243A>G; Heteroplasmy; Genetic diagnosis

Introduction

Mitochondrial diseases comprise a group of disorders caused by mutations in both mitochondrial DNA (mtDNA) and nuclear DNA (nDNA), affecting the encoding of proteins and essential components for mitochondrial function [1,2].

Mutations in mtDNA can compromise the cell's bioenergetic efficiency, primarily impacting tissues and organs with high energy demands. Among these disorders is mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome, which predominantly affects the nervous and muscular systems [3,4].

The clinical manifestations of MELAS typically appear in early life and are characterized by headaches, muscle weakness, hearing loss, lactic acidosis, and stroke-like episodes. Other reported symptoms include diabetes, vomiting, and short stature [5].

Most MELAS cases are associated with mtDNA mutations, with the m.3243A>G variant being the most frequent. This mutation, located in the MT-TL1 gene, which encodes tRNALeu, is responsible for approximately 80% of cases. Moreover, the expression and severity of the disease depend on the heteroplasmy level, which refers to the proportion of mutant mtDNA relative to the wild type. This percentage varies across tissues and can influence both the onset and severity of symptoms. For this reason, this study presents the clinical cases of two Mexican families with suspected MELAS, in whom the presence of this mutation was identified [3,5].

Case 1

A 50-year-old woman and her two sons, aged 24 and 14, visited the laboratory to evaluate the presence of the m.3243A>G variant associated with MELAS syndrome. As a family history, in 2004, the same study was conducted on the mother's sister, who presented vomiting, seizures, and recurrent headaches. Genetic analysis confirmed the presence of the variant with a 31% heteroplasmy level, along with the identification of the mitochondrial haplogroup B2 [6].

Since the younger son had begun to exhibit characteristic MELAS symptoms, such as muscle weakness and seizures, along with elevated lactic acid levels in laboratory tests, molecular analysis was performed on all three family members. This also allowed for an assessment of possible maternal inheritance of the mutation. For the diagnosis, a peripheral blood sample was obtained, from which DNA was extracted. The mitochondrial genome region containing the m.3243A>G variant was then amplified by PCR. Following PCR, genotyping by restriction fragment length polymorphism (RFLP) analysis was performed. The presence of the mutation in all three family members was confirmed through agarose gel electrophoresis (Figure 1).

Citation: Balderas Correa JJ, Romo Calvillo HB, Sánchez Mendoza AE, Luna Muñoz J, Montiel Sosa JF. Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-Like Episodes (MELAS), in Two Mexican Families. Austin J Clin Case Rep. 2025; 12(1): 1351.